Northern Gritstone
Overview
Northern Gritstone is an independent investment company dedicated to fostering the growth of innovative businesses in the North of England. Established with the support of the Universities of Manchester, Leeds, and Sheffield, the firm focuses on commercializing science and technology ventures that originate from these institutions and the broader region. By providing funding and strategic support, Northern Gritstone aims to transform research and intellectual property into successful, high-impact enterprises. The company's investment strategy centers on sectors such as deep technology and life sciences, including areas like semiconductor design, novel materials, secure computing, artificial intelligence, health technology, and gene therapies. Northern Gritstone seeks to partner with visionary teams possessing strong intellectual property and the ambition to make a positive global impact. Their approach encompasses supporting companies from early stages through to later growth phases, emphasizing long-term partnerships that deliver both attractive returns and societal benefits. Since its inception, Northern Gritstone has built a diverse portfolio of companies, including QV Bioelectronics, Opteran, Simanalytica, Imperagen, Silveray, Crucible Therapeutics, Iceotope, Mimetrik, AssetCool, Optalysys, Floreon, Pragmatic Semiconductor, Pencil Biosciences, adsilico, Phagenesis, Cavero Quantum, MicroLub, Exciting Instruments, Partful, Re:course, Auxetec, Phlux Technology, Bettering Our Worlds (BOW), and Apini Therapeutics. The firm operates under the philosophy of 'profit with purpose,' aiming to deliver attractive returns to shareholders while contributing positively to the economic and societal development of the North of England. Northern Gritstone's commitment to responsible investment is evident through its adherence to the United Nations Principles for Responsible Investment. The firm integrates environmental, social, and corporate governance considerations into its investment analysis and decision-making processes, actively promoting these principles within the investment industry. This dedication underscores Northern Gritstone's role as a catalyst for innovation and economic growth in the North of England, striving to create a 'Silicon Valley of the North' by nurturing and scaling high-potential businesses that emerge from the region's esteemed academic institutions.
Reach Northern Gritstone directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Northern Gritstone
What sectors does Northern Gritstone invest in?
Northern Gritstone invests in Technology, Healthcare, HealthTech, Artificial Intelligence, Life Sciences and Medtech, and is based in Leeds, United Kingdom. Northern Gritstone is listed as a venture capital in the ConnectSafely investor database.
What stage does Northern Gritstone invest at?
Northern Gritstone backs companies at Pre-Seed, Seed, Early Stage, Series A, Series B and Growth, writing cheques of 200K - 10M.
Which regions does Northern Gritstone invest in?
Northern Gritstone invests across United Kingdom.
Who are the partners at Northern Gritstone?
Team members listed for Northern Gritstone include Marion Bernard (Chief Investment Officer) and James Hadley (Chief Financial Officer).
How do I contact Northern Gritstone?
Northern Gritstone's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database